Corcept Therapeutics | CORT - 现金及等价物

股票价格
33.23
每天变化
-0.28 -0.84%
每月一次
-2.95%
每年
-42.71%
Q1 预测
31.18


金融业
股票价格
USD
资产
USD 836.65M
现金及等价物
USD 120.5M
销售成本
USD 2.55M
流动资产
USD 485.46M
流动负债
USD 166.09M
债务
USD 6.36M
EBIT
USD 4.49M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD 0.2
股本和储备
USD 647.81M
销售毛利
USD 199.58M
债务利息支出
USD 823.61M
利息收入
USD 5.02M
市值
USD 3.48B
净收入
USD 24.29M
营业费用
USD 197.64M
营业利润
USD 4.49M
普通股股本
USD 105.97M
PE价格收益
41.9
税前利润
USD 15.24M
销售收入
USD 202.12M
销售和管理费用
USD 114.75M
股票
USD 12.87M
贸易债权人
USD 40.44M
应收帐款人
USD 59.79M


现金及等价物 更改 日
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Alaunos Therapeutics USD 1.94M 941K 2025-09
ANI Pharmaceuticals USD 285.58M 22.98M 2025-12
Ardelyx USD 42.72M 47.32M 2025-09
Assertio Holdings USD 38.5M 8.59M 2025-09
Aurora Cannabis CAD 95.69M 44.47M 2025-09
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Canopy Growth CAD 298.06M 171.86M 2025-09
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
J&J USD 19.71B 1.48B 2025-12
Knight Therapeutics CAD 81.88M 4.06M 2025-09
Lexicon Pharmaceuticals USD 21.36M 41.52M 2025-06
Merck USD 18.17B 10.16B 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 158.54M 10.96M 2025-12
Pfizer USD 1.34B 295M 2025-09
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
TG Therapeutics USD 199.51M 21.2M 2025-12